SIBANNAC, INC. PURSUES PATENTED TECHNOLOGY AND IDENTIFIES PRODUCTS FOR NEW CONSUMER BRAND
Sibannac, Inc. (OTC Pink: SNNC) has announced its collaboration with a technology firm to develop wearable healthcare technology. This innovation utilizes discreet sensors and an app for personalized healthcare assessments. Sibannac intends to acquire this firm, facilitating research, development, and marketing. Additionally, the company is set to launch a new consumer brand focusing on anxiety, sleep, and pain relief products. Research on Kratom products is underway, targeting high-quality offerings for both their brand and white-label clients.
- Executed an NDA to develop wearable healthcare tech, enhancing product offerings.
- Plans to acquire a technology firm, which could accelerate R&D and market entry.
- New consumer brand targeting anxiety, sleep, and pain relief may attract significant consumer interest.
- Investing in Kratom product development may capture market share in a fragmented industry.
- None.
Scottsdale, Arizona, Dec. 13, 2021 (GLOBE NEWSWIRE) -- Sibannac, Inc. (OTC Pink: SNNC), a Nevada corporation (the “Company”), announced the following:
In its continued pursuit to develop next generation wellness products, the Company has executed an NDA with a technology firm with a patent pending wearable tech in the healthcare space. The innovation combines discreet, wearable sensors that communicate directly with a software application that interprets the data and allows for highly personalized healthcare assessments and dietary recommendations. The intent of the parties would be for Sibannac to acquire the tech firm and lead it through the research and development phase into brand development, marketing, and monetization strategies. Further disclosures will be made as discussions between the parties progress.
The Company will be unveiling its new consumer brand to the public in the near future. All of the brand architecture and positioning was accomplished in the last year. Further, market research was done to determine the initial products to bring to market. The top three product categories are anxiety, sleep and pain, and there is overlap between them.
The Campus
The Company is conducting research and development of various flavor profiles and delivery systems of Kratom in its Scottsdale facility. The Kratom market is highly fragmented and the few existing brands with any sizable distribution are confined to the smoke-shop segment, C-store and gas stations. Through our in-house development team, Sibannac is developing the highest quality Kratom products for our own brands as well as to offer to white-label clients. Through Eric Stoll and Lifetime Branding, Sibannac has access to physician and healthcare networks that can be tapped to distribute a first of its kind, luxury Kratom brand.
Overseeing manufacturing and logistics, both on and off premises, the Company has been fortunate to retain Eric Manfull to execute management’s vision and commitment to quality. Eric has overseen operations, warehousing, QA/QC and Engineering/Maintenance for several large manufacturing firms with 15 years of experience in the health and wellness industry.
He has overseen the production of more than 6,000 dietary supplement products and has formulated more than 100 products. Mr. Manfull served for over 22 years in the U.S. Navy, specializing in Maritime Engineering, Diving and Salvage and Surface Warfare & Naval Special Operations.
The Company will also be executing an awareness campaign beginning in the new year that will feature digital ads as well as physical billboard placement, in addition to interviews with the management team. For new investors, please see the NOHO, Inc. (OTC Pink: DRNK) shareholder call featuring a discussion with Sibannac’s CEO David Mersky, Lifetime’s Eric Stoll and Kevin Williams. Mr. Williams has been involved in several branding campaigns on behalf of leading brands in the herbal and natural supplement space: Event recording
Cautionary Note Regarding Forward-Looking Statements
This press release contains statements that constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements appear in a number of places in this release and include all statements that are not statements of historical fact regarding the intent, belief or current expectations of the Noho, Inc. (the “Company”), its directors or its officers with respect to, among other things: (i) financing plans; (ii) trends affecting its financial condition or results of operations; (iii) growth strategy and operating strategy. The words “may,” “would,” “will,” “expect,” “estimate,” “can,” “believe,” “potential” and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company’s ability to control, and actual results may differ materially from those projected in the forward-looking statements as a result of various factors. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors, which are, in some cases, beyond the Company's control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. Important factors that could cause actual results to differ materially from the company's expectations include, but are not limited to, those factors that are disclosed under the heading "Risk Factors" and elsewhere in documents filed by the company from time to time with the United States Securities and Exchange Commission and other regulatory authorities.
Media Contact: IR@theCampusCo.com
FAQ
What is Sibannac's recent partnership about?
What products will Sibannac focus on in its new consumer brand?
What is the stock symbol for Sibannac?
What is the significance of Sibannac's NDA with the tech firm?
How is Sibannac planning to enter the Kratom market?
